SI2640362T1 - Therapeutic compositions comprising rilpivirin hcl and tenovofir disoproxil fumarate - Google Patents

Therapeutic compositions comprising rilpivirin hcl and tenovofir disoproxil fumarate

Info

Publication number
SI2640362T1
SI2640362T1 SI201130276T SI201130276T SI2640362T1 SI 2640362 T1 SI2640362 T1 SI 2640362T1 SI 201130276 T SI201130276 T SI 201130276T SI 201130276 T SI201130276 T SI 201130276T SI 2640362 T1 SI2640362 T1 SI 2640362T1
Authority
SI
Slovenia
Prior art keywords
tenovofir
rilpivirin
hcl
therapeutic compositions
disoproxil fumarate
Prior art date
Application number
SI201130276T
Other languages
Slovenian (sl)
Other versions
SI2640362T2 (en
Inventor
Reza Oliyai
Lauren Wiser
Mark Menning
Original Assignee
Gilead Sciences, Inc.
Janssen R&D Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences, Inc., Janssen R&D Ireland filed Critical Gilead Sciences, Inc.
Priority claimed from PCT/US2011/061515 external-priority patent/WO2012068535A1/en
Publication of SI2640362T1 publication Critical patent/SI2640362T1/en
Publication of SI2640362T2 publication Critical patent/SI2640362T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI201130276T 2010-11-19 2011-11-18 Therapeutic compositions comprising rilpivirin hcl and tenovofir disoproxil fumarate SI2640362T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41560010A 2010-11-19 2010-11-19
PCT/US2011/061515 WO2012068535A1 (en) 2010-11-19 2011-11-18 Therapeutic compositions comprising rilpivirine hcl and tenofovir disoproxil fumarate
EP11791161.0A EP2640362B2 (en) 2010-11-19 2011-11-18 Therapeutic compositions comprising rilpivirin hcl and tenovofir disoproxil fumarate

Publications (2)

Publication Number Publication Date
SI2640362T1 true SI2640362T1 (en) 2015-01-30
SI2640362T2 SI2640362T2 (en) 2022-04-29

Family

ID=58457912

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201130276T SI2640362T2 (en) 2010-11-19 2011-11-18 Therapeutic compositions comprising rilpivirin hcl and tenovofir disoproxil fumarate

Country Status (2)

Country Link
CY (1) CY1116115T1 (en)
SI (1) SI2640362T2 (en)

Also Published As

Publication number Publication date
SI2640362T2 (en) 2022-04-29
CY1116115T1 (en) 2017-02-08

Similar Documents

Publication Publication Date Title
HK1190064A1 (en) Therapeutic compositions comprising rilpivirin hcl and tenovofir disoproxil fumarate
EP2542086A4 (en) Compounds and therapeutic uses thereof
EP2646468A4 (en) Anti-ngf compositions and use thereof
EP2739144A4 (en) Compounds and therapeutic uses thereof
HK1201454A1 (en) Therapeutic agents and uses thereof
GB2501611B (en) Alpha-2-macroglobulin compositions and therapeutic uses
PL2605757T3 (en) Nalbuphine-based formulations and uses thereof
EP2588127A4 (en) Dipeptide linked medicinal agents
PT2521445T (en) Formulation and use thereof
PT2565182T (en) Novel amide derivative and use thereof as medicine
PT2563806E (en) Human leukolectins and uses thereof
GB201011411D0 (en) Therapeutic compounds and their use
EP2694587A4 (en) Biocompatible polycaprolactone fumarate formulations
SG10201602111VA (en) Formulations Comprising Methylthioninium Chloride
EP2660249A4 (en) Peptide derivative and use thereof
HK1182712A1 (en) Therapeutic agents 976 976
SI2640362T2 (en) Therapeutic compositions comprising rilpivirin hcl and tenovofir disoproxil fumarate
ZA201209021B (en) Therapeutic peptide composition and method
GB201003741D0 (en) Methods and therapeutic compositions
AU332227S (en) Therapeutic pillow
GB201006380D0 (en) Excipients and their use
EP2657236A4 (en) Novel 2-alkynyl-n9-propargyladenine and medicinal use thereof
GB201016149D0 (en) Effective and essential bedding and table clothing
GB201012660D0 (en) Inhaler and formulation